Home / Markets / News / Aurobindo Pharma rallies 6% as Q2 net profit rises 26% YoY to Rs 805.65 cr

Aurobindo Pharma rallies 6% as Q2 net profit rises 26% YoY to Rs 805.65 cr

The company's consolidated total revenue from operations stood at Rs 6,483.44 crore.

markets, stock market, sensex, nifty, shares, growth, profit, economy, gain

Premium

The company's board has also approved a second interim dividend of 125 per cent at Rs 1.25 per equity share of Re 1 for the financial year 2020-21.

SI Reporter New Delhi

2 min read Last Updated : Nov 12 2020 | 10:40 AM IST

Shares of Aurobindo Pharma, the Hyderabad-based pharma company, surged as much as 5.88 per cent to Rs 858.80 apiece on the BSE on Thursday, a day after the company reported a 26 per cent increase in consolidated net profit at Rs 805.65 crore for the second quarter ended September 30 (Q2FY21). The company had posted a consolidated net profit of Rs 639.53 crore in the same quarter last fiscal.

At 10:20 AM, the stock was trading over 5 per cent higher at Rs 853 as against 0.45 per cent decine in the benchmark S&P BSE Sensex at 43,399.24 levels. Aurobindo

Topics : Aurobindo Pharma Buzzing stocks Markets Q2 results

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in